Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.3904
+0.0304 (8.44%)
At close: May 12, 2025, 4:00 PM
0.3900
-0.0004 (-0.10%)
After-hours: May 12, 2025, 7:59 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $26.17 million as of May 12, 2025. Its market cap has decreased by -86.84% in one year.
Market Cap
26.17M
Enterprise Value
-43.81M
1-Year Change
-86.84%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $26.17M, a decrease of -97.56%. That is a compound annual growth rate of -53.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 24.13M | -65.91% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |